天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ITOLIZUMAB (monoclonal antybody)

ITOLIZUMAB (monoclonal antybody) Struktur
1116433-11-4
CAS-Nr.
1116433-11-4
Englisch Name:
ITOLIZUMAB (monoclonal antybody)
Synonyma:
EQ-001;Itolizumab;Itolizumab (anti-CD6);Research Grade Itolizumab;ITOLIZUMAB (monoclonal antybody);Research Grade Itolizumab(DHD87601)
CBNumber:
CB93110631
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

ITOLIZUMAB (monoclonal antybody) Eigenschaften

Aggregatzustand
Liquid
Farbe
Colorless to light yellow

Sicherheit

ITOLIZUMAB (monoclonal antybody) Chemische Eigenschaften,Einsatz,Produktion Methoden

ITOLIZUMAB (monoclonal antybody) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ITOLIZUMAB (monoclonal antybody) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 19)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Aladdin Scientific
tp@aladdinsci.com United States 57505 58
Shanghai YuanYe Biotechnology Co., Ltd. 021-61312847; 18021002903
 3008007409@qq.com China 71829 60
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994
 2853530910@QQ.com China 8011 62
Guangzhou Hongyuan Chemical Co.,Ltd 15817493340
 981810490@qq.com China 1566 58
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062
 422450190@qq.com China 10356 58
Bide Pharmatech Ltd. 400-1647117 13681763483
 product02@bidepharm.com China 62072 58
TargetMol Chemicals Inc. 4008200310
 marketing@tsbiochem.com China 24683 58
Biolab Reagents 027-65279366 18108604356
 products@biolabreagent.com China 9868 58
Wuhan Jingkangen Biomedical Technology Co., Ltd 13720134139 086-15871494362 13720134139
 orders@jknbiochem.com China 6111 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627
 customer_service@efebio.com China 11973 58
  • ITOLIZUMAB (monoclonal antybody)
  • Itolizumab
  • Research Grade Itolizumab(DHD87601)
  • Itolizumab (anti-CD6)
  • EQ-001
  • Research Grade Itolizumab
  • 1116433-11-4
Copyright 2019 ? ChemicalBook. All rights reserved